Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2021-04-12 Regulatory Filings
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release from Implanet announcing that it received TGA clearance for its MADISONTM total knee prosthesis in Australia. It discusses regulatory milestones (TGA clearance, FDA 510(k), CE marking) and mentions an upcoming Q1 2021 revenue announcement. This type of announcement, detailing a specific operational or regulatory achievement outside of routine financial reporting (like 10-K or ER), fits best under the general 'Regulatory Filings' or 'Miscellaneous' category, as it is not a formal financial report, a management change, a dividend notice, or a specific legal update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a significant, non-standard regulatory/operational update that doesn't fit a more specific code like ER, AR, or LTR. The document length is short (3461 chars), but it is the primary content, not an announcement *about* another report.
2021-04-12 English
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document explicitly announces the 'Holding of Implanet's AGM on May 5, 2021'. It details the procedures for online and postal voting, the date, time, and location (behind closed doors) of the Annual General Meeting (AGM). This content directly relates to the preparation and announcement of the AGM proceedings, matching the definition for AGM Information (AGM-R). Although it mentions documents will be made available later, the primary focus of this press release is the meeting itself.
2021-03-31 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 98% confidence The document explicitly announces the 'Tenue de l'Assemblée Générale Implanet le 5 mai 2021' (Holding of the Implanet General Meeting on May 5, 2021). It details the procedures for holding the meeting 'à huis clos' (behind closed doors) due to COVID-19 restrictions, provides links for live web conference viewing, and outlines the modalities for remote voting ('Vote par internet' and 'vote par correspondance'). This content directly relates to the preparation, announcement, and logistics of the Annual General Meeting (AGM). Therefore, the classification is AGM-R (AGM Information). The document is an announcement/information release regarding the AGM, not the voting results (DVA) or a proxy statement (PSI), although it contains elements of both, the primary focus is the meeting itself.
2021-03-31 French
Informations privilégiées / Autres communiqués
M&A Activity Classification · 99% confidence The document is a press release dated March 30, 2021, announcing that Implanet has finalized an agreement to acquire OSD, a spine implant manufacturer. It details the strategic rationale, the structure of the acquisition (cash and stock/convertible notes), and mentions that the issuance of securities (ORA) will be subject to shareholder approval at the upcoming Annual General Meeting (AGM) on May 5, 2021. This document is an announcement detailing a significant corporate transaction (M&A) and related financing/capital structure changes, rather than the final legal filing for the M&A itself (TAR) or a general financing update (CAP). Since it details the terms of a takeover/acquisition proposal, the most fitting category is M&A Activity (TAR). It is not a formal regulatory filing like a 10-K, nor is it a simple announcement of a report (RPA).
2021-03-30 French
Inside Information / Other news releases
M&A Activity Classification · 99% confidence The document is a press release dated March 30, 2021, announcing that Implanet has finalized an agreement to acquire OSD, a spine surgery implant manufacturer. It details the terms of the acquisition, including share capital valuation, payment structure (sale and contributions), and the issuance of new shares/bonds redeemable in shares (BRS). Crucially, it mentions that the issuance of BRS is subject to shareholder approval at a Shareholders' Meeting scheduled for May 5, 2021. This document is an announcement detailing a significant corporate transaction (M&A) and related financing/capital structure changes, rather than a formal regulatory filing like a 10-K or an earnings release. Since it is a major corporate action announcement detailing financing and acquisition terms, it fits best under Capital/Financing Update (CAP) or M&A Activity (TAR). Given the heavy focus on the acquisition structure, financing (bond issuance), and the required shareholder vote, 'CAP' (Capital/Financing Update) is highly relevant, but 'TAR' (M&A Activity) is the primary driver. However, the document structure strongly resembles a standard press release announcing a major corporate event, which often falls under general regulatory announcements if a more specific category isn't perfect. Since the core event is the acquisition, TAR is appropriate. If TAR is too narrow, CAP covers the financing aspect. Given the explicit focus on 'Acquisition of 100% of OSD's share capital' and the creation of a 'new benchmark player,' TAR (M&A Activity) is the most precise fit for the primary event being communicated.
2021-03-30 English
Informations privilégiées / Autres communiqués
M&A Activity Classification · 99% confidence The document is a press release dated March 17, 2021, announcing that IMPLANET has reached an agreement with the founders of Orthopaedic & Spine Development (OSD) for a majority stake acquisition. It details the valuation (€4.2M), the structure of the deal (cash, vendor credit, Implanet shares), and mentions that the final acquisition terms will be communicated later. Crucially, it states: "Avant le 31 mars 2021, Implanet convoquera une Assemblée Générale afin de soumettre à ses actionnaires l'accord de prise de contrôle." This indicates a significant corporate action involving financing and shareholder approval related to a merger/acquisition. This falls under the scope of M&A Activity (TAR) or Capital/Financing Update (CAP). Since the primary focus is the proposed takeover/acquisition of OSD, 'TAR' (M&A Activity) is the most appropriate primary classification. It is not a standard regulatory filing like 10-K or IR, nor is it just an announcement of a report (RPA/RNS).
2021-03-17 French

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.